XML 49 R37.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule of Assets and Liabilities assumed (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Business Acquisition [Line Items]      
Fair value of common shares issued   $ 480,776 $ 25,160,223
Goodwill $ 14,706,818 14,706,818
Advanced Conceptions, Inc. and Idaho Molecular, Inc. [Member]      
Business Acquisition [Line Items]      
Fair value of common shares issued 25,640,999    
Payable to shareholders    
Fair value of contingent shares 8,850,626   8,850,626
Fair value of contingent warrants 1,781,374   1,781,374
Business combination, consideration transferred 36,272,999 580,135  
Cash 1,196,243   1,196,243
Accounts receivables 31,170   31,170
Prepaid expenses and other current assets 70,321   70,321
Property and equipments 408,173   408,173
Research and development in process 26,101,000   26,101,000
Non competition agreements 1,094,000   1,094,000
Accounts payable and accrued other expenses (1,170,867)   (1,170,867)
Deferred tax liability (6,845,587) $ (101,593) (6,845,587)
Total indentifiable net assets 20,884,453   20,884,453
Goodwill 15,388,546   15,388,546
Total 36,272,999   36,272,999
Previously Reported [Member] | Advanced Conceptions, Inc. and Idaho Molecular, Inc. [Member]      
Business Acquisition [Line Items]      
Fair value of common shares issued 25,160,223    
Payable to shareholders 100,000    
Fair value of contingent shares 8,684,669   8,684,669
Fair value of contingent warrants 1,747,972   1,747,972
Business combination, consideration transferred 35,692,864    
Cash 1,196,243   1,196,243
Accounts receivables 31,170   31,170
Prepaid expenses and other current assets 70,321   70,321
Property and equipments 408,173   408,173
Research and development in process 26,101,000   26,101,000
Non competition agreements 1,094,000   1,094,000
Accounts payable and accrued other expenses (1,069,274)   (1,069,274)
Deferred tax liability (6,845,587)   (6,845,587)
Total indentifiable net assets 20,986,046   20,986,046
Goodwill 14,706,818   14,706,818
Total 35,692,864   35,692,864
Revision of Prior Period, Adjustment [Member] | Advanced Conceptions, Inc. and Idaho Molecular, Inc. [Member]      
Business Acquisition [Line Items]      
Fair value of common shares issued 480,776    
Payable to shareholders (100,000)    
Fair value of contingent shares 165,957   165,957
Fair value of contingent warrants 33,402   33,402
Business combination, consideration transferred 580,135    
Cash  
Accounts receivables  
Prepaid expenses and other current assets  
Property and equipments  
Research and development in process  
Non competition agreements  
Accounts payable and accrued other expenses (101,593)   (101,593)
Deferred tax liability  
Total indentifiable net assets (101,593)   (101,593)
Goodwill 681,728   681,728
Total $ 580,135   $ 580,135